Potential impact of European Medicines Agency measures to minimise risk of serious side effects on JAKi prescribing and utilisation in the UK

Zixing Tian, Lianne Kearsley-Fleet, James Galloway, Kath Watson, Mark Lunt, BSRBR-RA Contributors Group, Kimme L. Hyrich

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Potential impact of European Medicines Agency measures to minimise risk of serious side effects on JAKi prescribing and utilisation in the UK'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences